| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 564152000 |
Plural carboxamide groups containing or containing plural carbonyls bonded directly to the same nitrogen
| 74 |
| 564192000 |
Substituent Q is acyclic
| 62 |
| 564161000 |
Substituent Q contains benzene ring
| 45 |
| 564133000 |
Preparing directly by amidation of -C(=O)X group, where X is O- or halogen
| 44 |
| 564124000 |
Preparing directly from cyano containing compound
| 23 |
| 564191000 |
Alicyclic ring and an atom other than oxygen, carbon, or hydrogen in substituent Q | 3 |
| 20080312470 | Mono, Di & Tri Cyclic Compounds Useful for Lowering IgE Concentrations - The present invention is directed to novel compounds which are derivatives of minocycline or doxycycline, pharmaceutical compositions containing same and use thereof in lowering excess IgE levels in a mammal suffering from a disease where IgE is pathogenic. | 12-18-2008 |
| 20090312576 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF 3-(AMINO)-3-CYCLOBUTYLMETHYL-2-HYDROXY-PROPIONAMIDE OR SALTS THEREOF - In one embodiment, the present application relates to a process of making a compound of formula I: | 12-17-2009 |
| 20160060210 | Process for the Preparation of Lacosamide and Its Novel Intermediate - An improved, cost effective process for the preparation of Lacosamide is disclosed. A novel intermediate of formula (IV) and a process for preparation of the novel intermediate is also disclosed. | 03-03-2016 |
| 564148000 |
Hydrazine containing | 3 |
| 20140357894 | VISUAL DETECTION OF FLUORIDE IONS - Dendrimer-hydrazides are coupled to polycyclic aromatic hydrocarbons for use in the visual detection of the presence of low levels of fluoride in a sample. The dendrimers can have a phenyl core, a first generation of aralkyl ethers, and an optional second generation of aralkyl ethers. The compounds form gels with solvents. In the presence of fluoride ion, the gels undergo color changes and/or gel to liquid phase change. | 12-04-2014 |
| 20100048952 | DIHYDRAZIDE COMPOUNDS, PREPARATION AND USES THEREOF - Disclosed are dihydrazide compounds having formula (I) or (II), wherein R | 02-25-2010 |
| 20160176809 | PROCESSES FOR MAKING HYDRAZIDES | 06-23-2016 |
| 564132000 |
Preparing directly from carbon monoxide or carbon dioxide | 2 |
| 20120071690 | PRODUCTION OF FORMAMIDES - A process is proposed for production of formamides by reaction of carbon dioxide with hydrogen in a hydrogenation reactor I in the presence of
| 03-22-2012 |
| 20140018576 | Method for Preparing Formamide Compounds - The present invention relates to a method for preparing formamide compounds using carbon dioxide, and to the use of said method for manufacturing vitamins, pharmaceutical products, adhesives, acrylic fibres, synthetic leathers, pesticides and fertilisers. The invention also relates to a method for manufacturing vitamins, pharmaceutical products, adhesives, acrylic fibres, synthetic leathers, pesticides and fertilisers which includes a step of preparing formamide compounds by the method according to the invention. | 01-16-2014 |
| 564188000 |
Plural alicyclic rings in substituent Q | 1 |
| 20150297761 | PEPTIDIC STRUCTURES INCORPORATING AN AMINO ACID METAL COMPLEX AND APPLICATIONS IN MAGNETIC RESONANCE IMAGING - A method for increasing the relaxivity of a contrast agent having a metal ion complexed to a chelator is disclosed. The metal ion complex is tethered to the remainder of the molecule by at least two points of attachment such that local motion is limited and higher relaxivity can be achieved. In one non-limiting example version of the invention, the alanine analogue of Gd(DOTA), Gd(DOTAla) wherein Gd is gadolinium and DOTA is 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid was integrated into polypeptide structures. This resulted in very rigid attachment of the metal ion complex to the peptide backbone. Rigid molecular structures provide fewer degrees of rotational freedom, resulting in greater control over the rotational dynamics and resultant relaxivity. In the case of Gd(DOTAla), the metal complex is tethered to the peptide via the amino acid side chain to the DOTA moiety and via a dative bond from an amide oxygen to the Gd(III) ion. | 10-22-2015 |
| 564146000 |
Preparing directly by nitration | 1 |
| 20120059190 | NOVEL NITRATION OF TETRACYCLINES - The invention in one embodiment is directed to a method of preparing a compound of formula 1, | 03-08-2012 |
| Entries |
| Document | Title | Date |
|---|
| 20090171119 | PROCESS FOR PREPARING MENTHYLAMIDES - An improved process for preparing menthylamides is provided by reacting menthyl halides with magnesium or lithium and subsequent reaction with an isocyanate, a heterocycle or a carbamoyl chloride. | 07-02-2009 |
| 20110034728 | CATALYST FOR REACTING CARBOXYLIC ACID NITRILES - The present invention relates to a catalyst for reacting carbonitriles with water, wherein the catalyst comprises at least 60% by weight of manganese dioxide with an empirical formula MnO | 02-10-2011 |
| 20110077429 | METHOD AND CATALYST COMPOSITION FOR PREPARING AMIDE - The present invention provides a catalyst composition for preparing an amide, including an amino acid ionic liquid having a cation of formula (I) | 03-31-2011 |
| 20110105793 | METHOD FOR SEPARATING AMIDE FROM AMINO ACID IONIC LIQUID - The present invention provides a method for separating an amide from an amino acid ionic liquid. The method includes the step of providing a polar solvent and an extracting agent to the amino acid ionic liquid, so as to separate the amide from the amino acid ionic liquid. In the method of the present invention, there is no need to add ammonium for neutralization, such that no byproduct, ammonium sulfate, is formed. In addition, after the amide is separated from the amino acid ionic liquid, the amino acid ionic liquid can be recycled. | 05-05-2011 |
| 20110275857 | Antibody-Guided Fragment Growth - The present invention relates to an improved method for drug discovery comprising using contact residue information derived from antibody-protein target interactions to help to direct the growth of small molecule fragments during the synthesis of a drug candidate. In particular, the present invention relates to the use of atomic structural information derived from anti-body-protein interactions to guide the growth of small molecular fragments during lead optimisation, thus generating small molecule compounds which can alter the biological activity of a target protein. | 11-10-2011 |
